Altered expression and subcellular distribution of GRK subtypes in the dopamine-depleted rat basal ganglia is not normalized by l-DOPA treatment.
about
GRK2: multiple roles beyond G protein-coupled receptor desensitizationSex differences in the activity of signalling pathways and expression of G-protein-coupled receptor kinases in the neonatal ventral hippocampal lesion model of schizophrenia.The role of GRK6 in animal models of Parkinson's disease and L-DOPA treatmentGRK3 suppresses L-DOPA-induced dyskinesia in the rat model of Parkinson's disease via its RGS homology domainCurrent Experimental Studies of Gene Therapy in Parkinson's DiseaseAllele specific analysis of the ADRBK2 gene in lymphoblastoid cells from bipolar disorder patients.Selective deletion of GRK2 alters psychostimulant-induced behaviors and dopamine neurotransmissionLentiviral overexpression of GRK6 alleviates L-dopa-induced dyskinesia in experimental Parkinson's disease.Increased G protein-coupled receptor kinase (GRK) expression in the anterior cingulate cortex in schizophreniaDistinct cellular and subcellular distributions of G protein-coupled receptor kinase and arrestin isoforms in the striatum.Cell-specific roles of GRK2 in onset and severity of hypoxic-ischemic brain damage in neonatal mice.Differential effects of inescapable stress on locus coeruleus GRK3, alpha2-adrenoceptor and CRF1 receptor levels in learned helpless and non-helpless rats: a potential link to stress resilience.Reduced expression of G protein-coupled receptor kinases in schizophrenia but not in schizoaffective disorderG Protein-coupled Receptor Kinases of the GRK4 Protein Subfamily Phosphorylate Inactive G Protein-coupled Receptors (GPCRs).G protein-coupled receptor kinases: more than just kinases and not only for GPCRsThe evolving impact of g protein-coupled receptor kinases in cardiac health and diseaseElimination of GRK2 from cholinergic neurons reduces behavioral sensitivity to muscarinic receptor activationCognitive effects of dopamine depletion in the context of diminished acetylcholine signaling capacity in mice.NMDA receptor regulation of levodopa-induced behavior and changes in striatal G protein-coupled receptor kinase 6 and β-arrestin-1 expression in parkinsonian rats.Haloperidol and clozapine differentially affect the expression of arrestins, receptor kinases, and extracellular signal-regulated kinase activationConstitutively active rhodopsin mutants causing night blindness are effectively phosphorylated by GRKs but differ in arrestin-1 bindingRich tapestry of G protein-coupled receptor signaling and regulatory mechanisms.Effect of Tianqi antitremor granules on behavioral manifestations and expression of G protein-coupled receptor kinase 6 and β-arrestin1 in levodopa-induced dyskinesia in a rat model of Parkinson's diseaseDistinct cortical and striatal actions of a β-arrestin-biased dopamine D2 receptor ligand reveal unique antipsychotic-like properties.Synthetic biology with surgical precision: targeted reengineering of signaling proteins.G protein-coupled receptor kinases as regulators of dopamine receptor functions.Ubiquitin ligase parkin promotes Mdm2-arrestin interaction but inhibits arrestin ubiquitinationOverexpression of GRK6 rescues L-DOPA-induced signaling abnormalities in the dopamine-depleted striatum of hemiparkinsonian rats.How does arrestin assemble MAPKs into a signaling complex?G Protein-Coupled Receptor Kinases in the Inflammatory Response and Signaling.Signal transduction in L-DOPA-induced dyskinesia: from receptor sensitization to abnormal gene expression.
P2860
Q24624571-DBB5D3FE-6B0B-4934-B9CB-4273AB4DB20AQ30470945-EA5DC650-AA44-4255-A7A8-6425580EE70FQ30506209-8888DD05-6054-4B32-985D-C45C2B1E9140Q30653115-873B055E-BE9A-411A-9C20-F3C1C8FA096CQ33627771-31CAE599-5815-4D47-BB4F-E800CC647586Q33695379-4CB18B0A-801E-434F-9916-911106B4BAB5Q34068943-D8959CBF-6877-455B-AF82-34F1304EF59CQ34105586-0C899013-70A7-4988-9AE2-9A5BCE86EDC3Q34254863-F72A24DF-C092-46E1-9B70-3B688DDA9B25Q34472138-75E7E99C-639B-4FE2-A67A-615B6EA0F088Q34997837-CDC0CEF4-62CF-4C86-B4FA-259C301C8B0AQ35024537-381AB81B-1F67-4B18-AA93-B1A861C1E82EQ35196371-F2AB5245-EF38-4C1D-A832-59680A54CE8EQ35536256-B8CD8B15-62D1-487F-BAEF-0E6A07730217Q35621624-262DBD44-E4B1-43D0-9E7C-F10FB4C18A30Q36000382-C486AC14-A438-4B13-93E8-9164246FFE94Q36190481-3D592AE9-B4D9-46AF-B029-038AFD191308Q36486037-3CC05931-6079-4056-98B5-D6BFF62E4904Q36738475-696FE4F7-94C3-49A9-BF93-85982C76CF0BQ37068695-17EF6E15-F599-4CC6-B0F8-652C809EB36DQ37174339-81FEA56C-1C93-4721-A20D-27855D72E900Q37178682-8EF1B69B-AA90-4C67-9ECB-B89142E1A7DCQ37396700-7CEC9686-3E0B-4773-A621-F88B2227ABDCQ37515058-95EA5DDD-7BA1-43DF-A78B-D4D5C1D0BA96Q38016028-8AEDE479-00BC-438C-ADFB-3B99F16210BDQ38834292-1B450C42-F9C1-4E61-8BAF-7F96E9265FD0Q42173591-49046978-B508-429F-B97A-A4A7E0E98156Q42512289-0A480BD2-4D6E-4846-95FA-3654B1A55741Q43084070-C4E6AEE1-72DC-465A-AAA3-0E369DB9C53DQ47740257-43E6A9DC-800B-4654-95DA-A601576370D5Q49357267-FF30E87F-B290-41F3-B48A-E2EEDECD7A9F
P2860
Altered expression and subcellular distribution of GRK subtypes in the dopamine-depleted rat basal ganglia is not normalized by l-DOPA treatment.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Altered expression and subcell ...... ormalized by l-DOPA treatment.
@en
Altered expression and subcell ...... ormalized by l-DOPA treatment.
@nl
type
label
Altered expression and subcell ...... ormalized by l-DOPA treatment.
@en
Altered expression and subcell ...... ormalized by l-DOPA treatment.
@nl
prefLabel
Altered expression and subcell ...... ormalized by l-DOPA treatment.
@en
Altered expression and subcell ...... ormalized by l-DOPA treatment.
@nl
P2093
P2860
P1476
Altered expression and subcell ...... ormalized by l-DOPA treatment.
@en
P2093
Eugenia V Gurevich
Evgeny Bychkov
Jeffrey L Benovic
M Rafiuddin Ahmed
Vsevolod V Gurevich
P2860
P304
P356
10.1111/J.1471-4159.2007.05104.X
P407
P577
2007-11-07T00:00:00Z